Anda Biopharma
Latest round
- Series A
Last raised
- Mar 2025
Total raised
- Undisclosed
Investors
- 5
About Anda Biopharma
Founded in 2018 and based in Shanghai, China, Anda Biopharma is a developer of AI-driven tumor neoantigen therapies. The company focuses on AI-driven tumor neoantigen therapy. It has created the AD-INN technology analysis platform. Its core products include PCNAT-01 (personalized neoantigen vaccine for pancreatic cancer). The company generates revenue by developing AI-driven tumor neoantigen therapies.
Who invested in Anda Biopharma
5 investors across 1 round
See all investors in Anda Biopharma
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Mar 24, 2025
Amount
Undisclosed
Investors
Questions about Anda Biopharma
Who invested in Anda Biopharma?
Anda Biopharma has 5 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Anda Biopharma raised?
Anda Biopharma has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Anda Biopharma last raise money?
Anda Biopharma's most recent round on record is a Series A, in Mar 2025.
What does Anda Biopharma do?
Founded in 2018 and based in Shanghai, China, Anda Biopharma is a developer of AI-driven tumor neoantigen therapies.
Where is Anda Biopharma headquartered?
Anda Biopharma is headquartered in Shanghai, China.
Which VCs invest in companies like Anda Biopharma?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back biotechnology companies at Anda Biopharma's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Anda Biopharma? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.